[ Enter any part of the test name including alternates ]

All tests

Biochemical analysis

Cancer genetics

Cytogenetics

Genetics

Haematology

Microbiology

Tissue Immunology

Virology


 

 

login to site admin

 

  TEST DETAILS

BACK
Test: MERRF
Alternate names:
Description: MERRF is a multisystem disease typically characterized by myoclonus as the first symptom, followed by epilepsy, ataxia, weakness, and dementia. Other common clinical features include hearing loss, short stature, optic atrophy, and cardiomyopathy with Wolff-Parkinson-White (WPW) syndrome. The disease is caused by mutations in mitochondrial DNA. The most common mutation that accounts for 80% of the MERRF cases is 8344A>G in the MTTK1 gene. Due to genetic and clinical heterogeneity and multisystem dysfunction, we highly recommend the screening test (see Mitochondrial DNA Screen (Point Mutations and Deletions)) for a patient suspected of MERRF, unless a specific mutation has already been detected in the family.
Clinical:
Methodology: mtDNA
Turn around time: 4-6 weeks
Transit stability:
Comments: EDTA blood accepted, but not ideal
Sample: Frozen muscle biopsy or urine (room temp) preferred.
Type: Genetics
Method: Point mutation analysis
Consultant/scientist: Ms Surita Meldau
Tel: 021 404 4449
email: surita.meldau@nhls.ac.za
Contact for results: Ms Surita Meldau
Tel: 021 404 4449
email: surita.meldau@uct.ac.za
Delivery address C17 NHLS Labs, NGSH, Observatory, 7925
for samples: Cape Town